Anaplastic Large Cell Lymphoma (ALCL)

In January 2011, the American Food and Drug Administration (FDA) issued a communication to inform health care providers and the public about a possible association between breast implants and a type of anaplastic large cell lymphoma (ALCL).

Information published by the FDA is available in the following web pages:

FDA Medical Device Safety Communication: Reports of Anaplastic Large Cell Lymphoma (ALCL) in Women with Breast Implants

Questions and Answers about Anaplastic Large Cell Lymphoma (ALCL)

Further information from the Canadian Society of Plastic Surgeons:

Letter to CSPS Members – October 27, 2016

Letter to CSPS Members – November 4, 2015

MD Anderson Cancer Center – Frequently asked Questions – November 4, 2015